Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

TOBI Drug Profile

« Back to Dashboard

Which patents cover Tobi, and what substitute generic drugs are available?

Tobi is a drug marketed by Novartis Pharms and Novartis and is included in two NDAs. There are seven patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in TOBI is tobramycin. There are eighteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the tobramycin profile page.

Summary for Tradename: TOBI

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list44
Clinical Trials: see list5
Patent Applications: see list10,427
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOBI at DailyMed

Pharmacology for Tradename: TOBI

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms
TOBI
tobramycin
SOLUTION;INHALATION050753-001Dec 22, 1997RXYesYes► Subscribe► Subscribe
Novartis
TOBI PODHALER
tobramycin
POWDER;INHALATION201688-001Mar 22, 2013RXYesYes8,069,851► SubscribeY ► Subscribe
Novartis
TOBI PODHALER
tobramycin
POWDER;INHALATION201688-001Mar 22, 2013RXYesYes7,559,325► SubscribeY ► Subscribe
Novartis
TOBI PODHALER
tobramycin
POWDER;INHALATION201688-001Mar 22, 2013RXYesYes7,516,741► SubscribeY ► Subscribe
Novartis
TOBI PODHALER
tobramycin
POWDER;INHALATION201688-001Mar 22, 2013RXYesYes7,368,102► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TOBI

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms
TOBI
tobramycin
SOLUTION;INHALATION050753-001Dec 22, 19975,508,269► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: TOBI

Drugname Dosage Strength RLD Submissiondate
tobramycinInhalation Solution300 mg/5 mLTobi6/29/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc